These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 16493217

  • 1. Obstructive primary bladder neck disease: evaluation of the efficacy and safety of alpha1-blockers.
    Cisternino A, Zeccolini G, Calpista A, De Marco V, Prayer Galetti T, Iafrate M, Artibani W.
    Urol Int; 2006; 76(2):150-3. PubMed ID: 16493217
    [Abstract] [Full Text] [Related]

  • 2. alpha1-Adrenergic blockers in young men with primary bladder neck obstruction.
    Yang SS, Wang CC, Hsieh CH, Chen YT.
    J Urol; 2002 Aug; 168(2):571-4. PubMed ID: 12131312
    [Abstract] [Full Text] [Related]

  • 3. Use of alpha1-blockers in female functional bladder neck obstruction.
    Pischedda A, Pirozzi Farina F, Madonia M, Cimino S, Morgia G.
    Urol Int; 2005 Aug; 74(3):256-61. PubMed ID: 15812214
    [Abstract] [Full Text] [Related]

  • 4. alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.
    Rossi C, Kortmann BB, Sonke GS, Floratos DL, Kiemeney LA, Wijkstra H, de la ROSETTE JJ.
    J Urol; 2001 Jan; 165(1):38-41. PubMed ID: 11125359
    [Abstract] [Full Text] [Related]

  • 5. Endoscopic incision for functional bladder neck obstruction in men: long-term outcome.
    Suri A, Srivastava A, Singh KJ, Dubey D, Mandhani A, Kapoor R, Kumar A.
    Urology; 2005 Aug; 66(2):323-6. PubMed ID: 16040090
    [Abstract] [Full Text] [Related]

  • 6. Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women.
    Costantini E, Lazzeri M, Bini V, Zucchi A, Fioretti F, Frumenzio E, Porena M.
    Urol Int; 2009 Aug; 83(3):311-5. PubMed ID: 19829032
    [Abstract] [Full Text] [Related]

  • 7. Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists.
    Donohoe JM, Combs AJ, Glassberg KI.
    J Urol; 2005 Jan; 173(1):212-6. PubMed ID: 15592078
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D, Soebadi DM, Sugandi S, Birowo P, Djati W, Wahyudi I.
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [Abstract] [Full Text] [Related]

  • 9. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ, Guo YL, Gu FL.
    J Med; 1998 Nov; 29(5-6):289-304. PubMed ID: 10503165
    [Abstract] [Full Text] [Related]

  • 10. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
    Vanderbrink BA, Gitlin J, Toro S, Palmer LS.
    J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267
    [Abstract] [Full Text] [Related]

  • 11. Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy.
    Van Batavia JP, Combs AJ, Horowitz M, Glassberg KI.
    J Urol; 2010 Feb; 183(2):724-30. PubMed ID: 20022041
    [Abstract] [Full Text] [Related]

  • 12. Modified transurethral incision for primary bladder neck obstruction in women: a method to improve voiding function without urinary incontinence.
    Jin XB, Qu HW, Liu H, Li B, Wang J, Zhang YD.
    Urology; 2012 Feb; 79(2):310-3. PubMed ID: 22310746
    [Abstract] [Full Text] [Related]

  • 13. A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
    Bozlu M, Ulusoy E, Cayan S, Akbay E, Görür S, Akbay E.
    Scand J Urol Nephrol; 2004 Feb; 38(5):391-5. PubMed ID: 15764250
    [Abstract] [Full Text] [Related]

  • 14. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study.
    Athanasopoulos A, Gyftopoulos K, Giannitsas K, Fisfis J, Perimenis P, Barbalias G.
    J Urol; 2003 Jun; 169(6):2253-6. PubMed ID: 12771763
    [Abstract] [Full Text] [Related]

  • 15. Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.
    Martorana G, Giberti C, Di Silverio F, von Heland M, Rigatti P, Colombo R, Casadei G, Pacifico P.
    Eur Urol; 1997 Jun; 32(1):47-53. PubMed ID: 9266231
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular effects of alpha-blockers used for the treatment of symptomatic BPH: impact on safety and well-being.
    de Mey C.
    Eur Urol; 1998 Jun; 34 Suppl 2():18-28; discussion 47. PubMed ID: 9732825
    [Abstract] [Full Text] [Related]

  • 17. [Clinical efficacy of oxendolene (antiandrogen) and bunazosin hydrochloride (alpha-adrenergic blocker) in the treatment of prostatism--comparative study of oxendolone, bunazocin hydrochloride and their combination].
    Kumamoto Y, Tsukamoto T, Takagi Y, Furuya S, Yokoyama E, Takatsuka K, Tamiya T, Miyamoto S, Aoyama T, Honma A.
    Hinyokika Kiyo; 1987 Nov; 33(11):1921-41. PubMed ID: 2451412
    [Abstract] [Full Text] [Related]

  • 18. Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report.
    Palacio A, Hernández C, Marqués A, Prats J, Espinosa FJ.
    Arch Esp Urol; 2004 May; 57(4):451-60. PubMed ID: 15270291
    [Abstract] [Full Text] [Related]

  • 19. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T.
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [Abstract] [Full Text] [Related]

  • 20. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995 Apr; 166():1-12. PubMed ID: 7537599
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.